Low-Grade Ductal Carcinoma in situ Within a Fibroadenoma of the Breast: A Rare Case Report and Review of the Literature

References

• Carty NJ, Carter C, Rubin C, Ravichandran D, Royle GT, Taylor I. Management of fibroadenoma of the breast. Ann R Coll Surg Engl. 1995;77(2):127–130. PMID: 7793802; PMCID: PMC2502143.
   PubMed Web of Science ®Google Scholar
• Fukuda M, Nagao K, Nishimura R, et al. Carcinoma arising in fibroadenoma of the breast--A case report and review of the literature. Jpn J Surg. 1989;19(5):593–596. PMID: 2593394. doi:10.1007/BF02471669
   PubMedGoogle Scholar
• Deschênes L, Jacob S, Fabia J, Christen A. Beware of breast fibroadenomas in middle-aged women. Can J Surg. 1985;28(4):372–374. PMID: 2990650.
   PubMed Web of Science ®Google Scholar
• Pick PW, Iossifides IA. Occurrence of breast carcinoma within a fibroadenoma. A review. Arch Pathol Lab Med. 1984;108(7):590–594. PMID: 6329129.
   PubMed Web of Science ®Google Scholar
• Diaz NM, Palmer JO, McDivitt RW. Carcinoma arising within fibroadenomas of the breast. A clinicopathologic study of 105 patients. Am J Clin Pathol. 1991;95(5):614–622. PMID: 1850948. doi:10.1093/ajcp/95.5.614
   PubMed Web of Science ®Google Scholar
• Levi F, Randimbison L, Te VC, La Vecchia C. Incidence of breast cancer in women with fibroadenoma. Int J Cancer. 1994;57(5):681–683. PMID: 8194875. doi:10.1002/ijc.2910570512
   PubMed Web of Science ®Google Scholar
• Shojaku H, Hori R, Yoshida T, et al. Low-grade ductal carcinoma in situ (DCIS) arising in a fibroadenoma of the breast during 5 years follow-up: a case report. Medicine. 2021;100(10):e24023. PMID: 33725814; PMCID: PMC7969289. doi:10.1097/MD.0000000000024023
   PubMed Web of Science ®Google Scholar
• Marumoto A, Steinemann S, Furumoto N, Woodruff S. An uncommon pairing of common tumors: case report of ductal carcinoma in situ within fibroadenoma. Hawaii J Med Public Health. 2019;78(2):39–43. PMID: 30766763; PMCID: PMC6369888.
   PubMedGoogle Scholar
• Ooe A, Takahara S, Sumiyoshi K, Yamamoto H, Shiba E, Kawai J. Preoperative diagnosis of ductal carcinoma in situ arising within a mammary fibroadenoma: a case report. Jpn J Clin Oncol. 2011;41(7):918–923. PMID: 21693482. doi:10.1093/jjco/hyr075
   PubMed Web of Science ®Google Scholar
• Hammood ZD, Mohammed SH, Abdulla BA, et al. Ductal carcinoma in situ arising from fibroadenoma; a rare case with review of literature. Ann Med Surg. 2022;75:103449. PMID: 35386780; PMCID: PMC8977904. doi:10.1016/j.amsu.2022.103449
   PubMed Web of Science ®Google Scholar
• Tiwari A, Singh BMK, Varshney S, Yadav ML. Incidental detection of carcinoma in-situ in fibroadenoma of the breast in a young woman: a rare finding. Cureus. 2018;10(12):e3797. PMID: 30868011; PMCID: PMC6402743. doi:10.7759/cureus.3797
   PubMed Web of Science ®Google Scholar
• Skaane P, Engedal K. Analysis of sonographic features in the differentiation of fibroadenoma and invasive ductal carcinoma. AJR Am J Roentgenol. 1998;170(1):109–114. PMID: 9423610. doi:10.2214/ajr.170.1.9423610
   PubMed Web of Science ®Google Scholar
• Borecky N, Rickard M. Preoperative diagnosis of carcinoma within fibroadenoma on screening mammograms. J Med Imaging Radiat Oncol. 2008;52(1):64–67. PMID: 18373829. doi:10.1111/j.1440-1673.2007.01913.x
   PubMed Web of Science ®Google Scholar
• Kato F, Omatsu T, Matsumura W, et al. Dynamic MR findings of ductal carcinoma in situ within a fibroadenoma. Magn Reson Med Sci. 2011;10(2):129–132. PMID: 21720115. doi:10.2463/mrms.10.129
   PubMed Web of Science ®Google Scholar
• Goldman RL, Friedman NB. Carcioma of the breast arising in fibroadenomas, with emphasis on lobular carcinoma. A clinicopathologic study. Cancer. 1969;23(3):544–550. PMID: 5766498. doi:10.1002/1097-0142(196903)23:3<544::aid-cncr2820230305>3.0.co;2-f
   PubMed Web of Science ®Google Scholar
• More IA, Sandison AT. Triple carcinoma of the breast, one arising within a fibro-adenoma. J Pathol. 1973;109(3):263–265. PMID: 4352593. doi:10.1002/path.1711090313
   PubMed Web of Science ®Google Scholar
• Kuijper A, Preisler-Adams SS, Rahusen FD, Gille JJ, van der Wall E, van Diest PJ. Multiple fibroadenomas harbouring carcinoma in situ in a woman with a family history of breast/ovarian cancer. J Clin Pathol. 2002;55(10):795–797. PMID: 12354814; PMCID: PMC1769772. doi:10.1136/jcp.55.10.795
   PubMed Web of Science ®Google Scholar
• Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med. 1994;331(1):10–15. PMID: 8202095. doi:10.1056/NEJM199407073310103
   PubMed Web of Science ®Google Scholar
• Azzopardi JG, Ahmed A, Millis RR. Problems in breast pathology. Major Probl Pathol. 1979;11:i–xvi, 1–466. PMID: 547120.
   PubMedGoogle Scholar
• Kurosumi M, Itokazu R, Mamiya Y, et al. Invasive ductal carcinoma with a predominant intraductal component arising in a fibroadenoma of the breast. Pathol Int. 1994;44(12):874–877. PMID: 7866572. doi:10.1111/j.1440-1827.1994.tb01687.x
   PubMed Web of Science ®Google Scholar
• Weihua H, Yang H, Haixia L. Clinicopathological observation of four cases of intramammary fibroadenoma carcinoma. J Clin Exp Pathol. 2013;29(11):1242–1244. doi:10.13315/j.cnki.cjcep.2013.11.032
   Google Scholar
• Margolese RG, Cecchini RS, Julian TB, et al. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, Phase 3 clinical trial. Lancet. 2016;387(10021):849–856. PMID: 26686957; PMCID: PMC4792688. doi:10.1016/S0140-6736(15)01168-X
   PubMed Web of Science ®Google Scholar
• Correa C, McGale P, Taylor C, et al.; Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010(41):162–177. PMID: 20956824; PMCID: PMC5161078. doi:10.1093/jncimonographs/lgq039
   PubMedGoogle Scholar
• Rakovitch E, Nofech-Mozes S, Hanna W, et al. Multigene expression assay and benefit of radiotherapy after breast conservation in ductal carcinoma in situ. J Natl Cancer Inst. 2017;109(4):djw256. PMID: 30053207; PMCID: PMC6233855. doi:10.1093/jnci/djw256
   PubMedGoogle Scholar
• Gilleard O, Goodman A, Cooper M, Davies M, Dunn J. The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ. World J Surg Oncol. 2008;6(1):61. PMID: 18564426; PMCID: PMC2459183. doi:10.1186/1477-7819-6-61
   PubMedGoogle Scholar
• Rakovitch E, Sutradhar R, Nofech-Mozes S, et al. 21-gene assay and breast cancer mortality in ductal carcinoma in situ. J Natl Cancer Inst. 2021;113(5):572–579. PMID: 33369631. doi:10.1093/jnci/djaa179
   PubMedGoogle Scholar
• Taylor C, Correa C, Duane FK, et al.; Early Breast Cancer Trialists’ Collaborative Group. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35(15):1641–1649. PMID: 28319436; PMCID: PMC5548226. doi:10.1200/JCO.2016.72.0722
   PubMed Web of Science ®Google Scholar